Wen Jing Chen

Part of Lepu Medical Technology (Beijing) Co., Ltd., Lepu Pharmaceuticals Co., Ltd. is a Chinese company that manufactures medicinal products and medical devices. The company is based in Xiangcheng, China. The company was founded in 2010. The CEO is Xia Zhang. Lepu Pharmaceuticals Co. was acquired by Lepu Medical Technology (Beijing) Co., Ltd. from Lhasa Hengning Venture Capital LP on June 21, 2013 for $63.64 million.

Part of Lepu Medical Technology (Beijing) Co., Ltd., Shaanxi Qinming Medical Co., Ltd. is a Chinese company based in Baoji that specializes in the development, production, sales, and technical support of active implantable medical devices. The company's products include high-end medical devices such as implantable pacemakers, implantable neurostimulators, and electrode wires. The company has a good reputation in the medical device industry and has registered and listed its Qinming2312 and Qinming8631 series of implantable pacemakers, which are domestically produced medical device products with complete independent intellectual property rights. The company has a strict quality management system and has provided implantable pacemaker products and technical services for tens of thousands of clinical treatments of arrhythmia in China, saving many patients' lives and improving their quality of life. Shaanxi Qinming Medical Co. was acquired by Lepu Medical Technology (Beijing) Co., Ltd. on January 11, 2013 for $18.17 million.

Part of Lepu Medical Technology (Beijing) Co., Ltd., Beijing Ruixiang Taikang Technology Co., Ltd. is a company that wholesales medical equipment. The company is based in Beijing, China.

Zhejiang Xindonggang Pharmaceutical Co., Ltd. engages in the production of tablets, hard capsules, and active pharmaceutical ingredients. It manufactures and sells pharmaceutical intermediates and chemical products. The company was founded on January 18, 2001 and is headquartered in Taizhou, China.

Beijing Lepu Medical Technology Co., Ltd. engages in research and development, production and sales of in vitro diagnostic reagents and instruments. Its product series include molecular and nucleic acid detection, Xifensi thrombosis diagram, automatic fluorescence, Le Rui colloidal gold, Le Rui fluorescent, electrochemical, and Feite platelet test. The company was founded on January 7, 2008 and is headquartered in Beijing, China.